Newborn Genomics Program for Sick Infants
Part of Genetic & congenital clinical trials.
This study looks at using rapid DNA testing (genomics) in newborns and children who are very sick in the hospital (NICU or PICU). The goal is to see if finding a genetic cause early can help guide treatment and improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is in the hospital and very sick, in the NICU or PICU.
- Your child has been in the hospital less than a week, or their treatment has not worked as expected within a week.
- Doctors think your child might have a genetic condition, and there is no other clear reason for their illness.
- Your child's illness is not only due to being born early, jaundice, infection, a known genetic condition, or other clear causes like trauma.
- We can get a blood sample and a cheek swab from you (the mother) and your child for DNA testing.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study offers genetic testing for infants under 18 months who are in intensive care with certain health problems that may be genetic. The goal is to find a genetic cause quickly, which could guide care and treatment.
This research study tests a new way to screen newborns for hundreds of genetic diseases using a sample of their blood or saliva. It aims to find conditions early so your baby can get the right care sooner.
This study uses whole-genome sequencing (a DNA test that looks across the genome) for newborns in the intensive care unit when doctors suspect a genetic condition. It aims to help identify possible genetic causes of illness and improve understanding for families and clinicians.
This study looks at using whole genome sequencing in newborns and families with ongoing pregnancies, including those conceived naturally or with fertility treatments. It aims to better understand and manage genetic disease risks early.
This trial uses genetic testing to better understand the cause of a newborn’s birth defect and to help doctors choose more personalized treatment. It may help families get clearer answers and more targeted care.
This study uses a two-step genetic test (fast whole-genome sequencing followed by RNA testing if needed) to find the cause of unexplained, life-threatening conditions in newborns. The goal is to get a precise diagnosis faster, which could guide better care for your baby.
Hear when a new Genetic Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.